阿魏酸通过Bcl-xL/caspase-3通路促进成纤维细胞凋亡抑制纤维化机制研究
本研究探讨阿魏酸(FA)治疗瘢痕疙瘩的机制,通过生物信息学预测、分子对接与动力学模拟及体外实验验证。结果显示FA与Bcl-xL和caspase-3稳定结合,20、40、60 µM FA剂量依赖性下调Bcl-xL、增加cleaved caspase-3并促进瘢痕疙瘩成纤维细胞凋亡,40 µM后凋亡率平台期。结论为FA靶向Bcl-xL/caspase-3轴克服凋亡抵抗,40 µM为最大细胞死亡浓度。
要点
- FA剂量依赖性下调Bcl-xL、上调cleaved caspase-3促进瘢痕疙瘩成纤维细胞凋亡。
- 40 µM FA后凋亡率进入平台期,提示阈值驱动机制。
- FA与Bcl-xL和caspase-3结合稳定,为潜在抗纤维化靶点。
核心结论
- FA通过靶向Bcl-xL/caspase-3轴克服成纤维细胞凋亡抵抗,40 µM为最大细胞死亡浓度。
研究设计与样本
- 研究采用生物信息学重叠靶点识别与富集分析预测功能及通路。
- 采用分子对接和分子动力学模拟评估FA与靶点结合亲和力。
- 体外验证使用瘢痕疙瘩来源成纤维细胞,FA处理浓度为20、40、60 µM。
- 细胞活力用CCK-8法检测,凋亡用流式细胞术检测,Bcl-xL和caspase-3表达用Western blot分析。
主要发现
- 分子对接和动力学模拟预测FA与Bcl-xL和caspase-3具有稳定结合。
- 实验显示FA剂量依赖性下调Bcl-xL表达并增加cleaved caspase-3表达,伴随凋亡升高。
- 超过40 µM FA后凋亡率平台化,尽管caspase-3持续激活,提示促凋亡效应在该浓度达最大。
关键数值与推荐
- FA处理浓度为20、40、60 µM。
- 40 µM被确定为最大细胞死亡浓度。
临床怎么用
- FA可能作为靶向Bcl-xL/caspase-3轴的抗纤维化候选化合物。
- 40 µM可作为后续研究或转化中促凋亡效应的参考浓度。
局限性
- 研究仅进行体外细胞验证,缺乏体内实验数据。
- 凋亡率平台期与caspase-3持续激活的不一致机制仍需进一步探究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fibrotic disorders have always been a clinical challenge. The common pathogenesis is the persistence of apoptosis-resistant fibroblasts. Keloids, as a typical model of cutaneous fibrosis, exemplify this mechanism through hyperactive fibroblasts that evade programmed cell death. Ferulic acid (FA), a dietary phenolic compound, emerged as a candidate to overcome fibroblast apoptosis resistance. This study aims to explore the mechanisms by which FA may treat keloid. METHODS: Overlapping targets between FA and keloid were identified. Enrichment analyses were conducted to predict the associated functions and pathways. Following identification of hub targets, molecular docking and molecular dynamics simulations were employed to evaluate the binding affinity of FA. For in vitro validation, keloid-derived fibroblasts were treated with FA at 20, 40, and 60 µM. Cell viability was assessed by CCK-8 assay, apoptosis was measured by flow cytometry, and the expression of key targets Bcl-xL and caspase-3 was determined by Western blot analysis. RESULTS: Molecular docking and molecular dynamics simulations predicted that FA has stable binding with Bcl-xL and caspase-3. Experimentally, FA dose‑dependently downregulated Bcl‑xL expression and increased the cleaved caspase‑3 expression in keloid fibroblasts, accompanied by elevated apoptosis. The apoptotic rate plateaued beyond 40 µM FA despite continued caspase‑3 activation, indicating that the pro‑apoptotic effect reaches a maximum at this concentration. CONCLUSION: FA overcomes fibroblast apoptosis resistance by targeting the Bcl-xL/caspase-3 axis, with 40 µM identified as the concentration for maximal cell death. The discordance between upstream signaling and terminal apoptosis highlights a threshold-driven mechanism.
引用
- Chen Y, Wu H, Zhou Y, et al. Mechanistic study of ferulic acid in inhibiting fibrosis via promoting fibroblast apoptosis through Bcl-xL/caspase-3 signaling pathway. Burns. 2026. PMID: 42508097. doi:10.1016/j.burns.2026.108161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。